Airdate: Monday, December 12, 2022 Season: 9 Episode: 50
Guest: Phil Griffiths
In this episode of #ExpertAnswers join Phil Griffiths as he answers questions from a recent webinar where he draws from his experience as a telemetry user to discuss some important considerations for designing telemetry studies.
For more information, to watch the webinar, or access other resources, click here.
Associated Webinar: Experimental Design Considerations to Optimize Chronic Cardiovascular Telemetry Studies
Similar Podcasts
Talking Real Science with Oliver Wearing
Oliver Wearing shares what led him to study the relationship between cardiovascular physiology and the autonomic nervous system, how achieving his various positions and awards have allowed him to pursue his research goals, and where he hopes to take his work next.
Talking Real Science with Tanishq Vaidya
Tanishq is one of 10 winners of the inaugural Scientist.com STEM Research NIL Award. In this episode, he discusses his current research interests, projects, and where the road lies ahead for his future career aspirations in STEM.
#ExpertAnswers: Artur Fedorowoski on Cardiovascular Dysautonomia in Post-COVID-19
Artur Fedorowski explains CV dysautonomia as a specific sequalae of acute COVID-19 and guides the audience in the diagnostic work-up of PASC patients with suspected cardiovascular complications.
Related Content
Measurement of Cardiac Function Using Pressure-Volume Loops in Swine
Join Dr. Pedro Ferreira for a deep dive into his work using pressure-volume loops in large animal models of heart failure.
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval Exercise
Dr. Bert Bond and Max Weston present an overview on their study investigating the effects high-intensity interval exercise has on cerebrovascular health.
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection and Management
Artur Fedorowski, MD, PhD, describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.